[ad_1]
Visakhapatnam: AMTZ and his companions Transasia Diagnostics Private Limited, located Andhra Pradesh MedTech Zone (AMTZ) announced a development in Vizag city Diagnostic Techniques with the launch of ErbaMDX Monkeypox RT-PCR Kit, IndiaThe first indigenously developed testing solution for MPOX. This innovation marks a huge progress for the country Health care Scenarios and pandemic preparedness efforts.
The kit has received rigorous validation from the Indian Council of Medical Research (ICMR) and emergency authorisation from the Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health and Family Welfare. This validation underlines the accuracy and reliability of the kit and highlights India’s growing capabilities in critical health diagnostics.
The kit stands out due to its lyophilized components, which enables it to be shipped and stored at ambient temperatures. This feature is particularly important for regions with limited cold chain infrastructure, ensuring that critical diagnostic tools are accessible even in the most remote areas. The kit has a 12-month shelf life and zero cross-reactivity with other orthopoxviruses, promising exceptional accuracy and dependability.
Dr. Jitendra Sharma, MD and Founder CEO, AMTZ said, “The launch of the ErbaMDx Monkeypox RT-PCR kit is a significant milestone for both AMTZ and the country. It exemplifies our commitment to advancing healthcare technology and strengthens our role in protecting public health against emerging threats.”
The launch of the kit enhances diagnostic capabilities and demonstrates India’s leading position in global health innovation. As the country continues to be a leader in medical technology advancements, the collaboration between AMTZ and TransAsia Diagnostics is essential to drive future advancements and address global health challenges.
[ad_2]
Source link